SCHEMBL6206331

SCHEMBL6206331

O=C(NCC1CCCO1)c1c[nH]c2ccccc2c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 9/20 0.63
MAPT P10636 9/20 0.63
KDM4E B2RXH2 8/20 0.63
ALDH1A1 P00352 8/20 0.63
HSD17B10 Q99714 7/20 0.63
USP2 O75604 6/20 0.63
NPC1 O15118 5/20 0.63
RAB9A P51151 4/20 0.63
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
NPSR1 Q6W5P4 2/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
TSHR P16473 2/20 0.59
MAPK1 P28482 1/20 0.59
POLB P06746 5/20 0.58
TDP1 Q9NUW8 2/20 0.58
LMNA P02545 2/20 0.58
TP53 P04637 1/20 0.57
APOBEC3A P31941 1/20 0.56
APOBEC3G Q9HC16 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6206116 0.81 KDM4E (0.77) HPGDMAPTKDM4EALDH1A1HSD17B10
SCHEMBL6206120 0.79 ALDH1A1 (0.56) HPGDMAPTKDM4EALDH1A1HSD17B10
SCHEMBL6204950 0.78 MEN1 (0.67) HPGDMAPTKDM4EALDH1A1HSD17B10
SCHEMBL5309700 0.78 MAPT (1.00) HPGDMAPTKDM4EALDH1A1HSD17B10
SCHEMBL7845295 0.77 HPGD (1.00) HPGDMAPTALDH1A1HSD17B10USP2
SCHEMBL34468762 0.76 KDM4E (0.74) HPGDMAPTKDM4EALDH1A1HSD17B10
SCHEMBL14832062 0.74 HAT1 (0.54) HPGDALDH1A1NPSR1
SCHEMBL13162950 0.74 MAPT (0.77) HPGDMAPTKDM4EALDH1A1HSD17B10
SCHEMBL13162627 0.74 MAPT (0.77) HPGDMAPTKDM4EALDH1A1HSD17B10
SCHEMBL13162949 0.74 MAPT (0.77) HPGDMAPTKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP claimed
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US claimed
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP disclosed
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US disclosed